NJ State Employees Deferred Compensation Plan - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$557,511
-2.7%
8,3000.0%0.08%
+2.4%
Q2 2023$572,949
+43.2%
8,3000.0%0.08%
+33.9%
Q1 2023$400,226
-3.4%
8,3000.0%0.06%
-7.5%
Q4 2022$414,336
+22.2%
8,3000.0%0.07%
+15.5%
Q3 2022$339,0008,3000.06%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2023
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders